<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36795690</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>e0281929</StartPage><MedlinePgn>e0281929</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0281929</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0281929</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown origin. The objective of this research was to develop phenotype algorithms for SLE suitable for use in epidemiological studies using empirical evidence from observational databases.</AbstractText><AbstractText Label="METHODS">We used a process for empirically determining and evaluating phenotype algorithms for health conditions to be analyzed in observational research. The process started with a literature search to discover prior algorithms used for SLE. We then used a set of Observational Health Data Sciences and Informatics (OHDSI) open-source tools to refine and validate the algorithms. These included tools to discover codes for SLE that may have been missed in prior studies and to determine possible low specificity and index date misclassification in algorithms for correction.</AbstractText><AbstractText Label="RESULTS">We developed four algorithms using our process: two algorithms for prevalent SLE and two for incident SLE. The algorithms for both incident and prevalent cases are comprised of a more specific version and a more sensitive version. Each of the algorithms corrects for possible index date misclassification. After validation, we found the highest positive predictive value estimate for the prevalent, specific algorithm (89%). The highest sensitivity estimate was found for the sensitive, prevalent algorithm (77%).</AbstractText><AbstractText Label="CONCLUSION">We developed phenotype algorithms for SLE using a data-driven approach. The four final algorithms may be used directly in observational studies. The validation of these algorithms provides researchers an added measure of confidence that the algorithms are selecting subjects correctly and allows for the application of quantitative bias analysis.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Swerdel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0001-9491-2737</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramcharran</LastName><ForeName>Darmendra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Janssen Research and Development Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Authors JS and JH are employees of Janssen Research and Development and shareholders of Johnson &amp; Johnson. DR was an employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson and is currently affiliated with GSK.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36795690</ArticleId><ArticleId IdType="pmc">PMC9934349</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0281929</ArticleId><ArticleId IdType="pii">PONE-D-22-09946</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32(9):1699&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">16142863</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco CM, Rudy TE, Manzi S. Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory. Pain Med. 2003;4(1):39&#x2013;50. doi: 10.1046/j.1526-4637.2003.03001.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-4637.2003.03001.x</ArticleId><ArticleId IdType="pubmed">12873277</ArticleId></ArticleIdList></Reference><Reference><Citation>Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40(1):51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">24268009</ArticleId></ArticleIdList></Reference><Reference><Citation>Danila MI, Pons-Estel GJ, Zhang J, Vil&#xe1; LM, Reveille JD, Alarc&#xf3;n GS. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford). 2009;48(5):542&#x2013;5. doi: 10.1093/rheumatology/kep012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kep012</ArticleId><ArticleId IdType="pmc">PMC2722801</ArticleId><ArticleId IdType="pubmed">19233884</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144&#x2013;50. doi: 10.1097/BOR.0000000000000480</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000480</ArticleId><ArticleId IdType="pmc">PMC6026543</ArticleId><ArticleId IdType="pubmed">29251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, et al.. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20(e2):e243&#x2013;e52. doi: 10.1136/amiajnl-2013-001930</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001930</ArticleId><ArticleId IdType="pmc">PMC3861914</ArticleId><ArticleId IdType="pubmed">23837993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tench CM, McCurdie I, White PD, D&#x2019;Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000;39(11):1249&#x2013;54. doi: 10.1093/rheumatology/39.11.1249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/39.11.1249</ArticleId><ArticleId IdType="pubmed">11085805</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaboni A, Ibanez D, Gladman DD, Urowitz MB, Moldofsky H. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol. 2006;33(12):2453&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17143980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cezarino RS, Cardoso JR, Rodrigues KN, Magalh&#xe3;es YS, Souza TY, Mota L, et al.. Chronic low back pain in patients with systemic lupus erythematosus: prevalence and predictors of back muscle strength and its correlation with disability. Rev Bras Reumatol Engl Ed. 2017;57(5):438&#x2013;44. doi: 10.1016/j.rbre.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbre.2017.03.003</ArticleId><ArticleId IdType="pubmed">28461080</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Hripcsak G, Ryan PB. PheValuator: Development and evaluation of a phenotype algorithm evaluator. Journal of Biomedical Informatics. 2019;97:103258. doi: 10.1016/j.jbi.2019.103258</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103258</ArticleId><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Casey C, Carroll RJ, Wheless L, Denny JC, Crofford LJ. Developing Electronic Health Record Algorithms That Accurately Identify Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017;69(5):687&#x2013;93. doi: 10.1002/acr.22989</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22989</ArticleId><ArticleId IdType="pmc">PMC5219863</ArticleId><ArticleId IdType="pubmed">27390187</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Schuemie M, Murray G, Ryan PB. PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation. J Biomed Inform. 2022:104177. doi: 10.1016/j.jbi.2022.104177</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104177</ArticleId><ArticleId IdType="pubmed">35995107</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research. Communications in Statistics&#x2014;Simulation and Computation. 2009;38(6):1228&#x2013;34.</Citation></Reference><Reference><Citation>Mortensen K, Song PH. Minding the gap: a decomposition of emergency department use by Medicaid enrollees and the uninsured. Med Care. 2008;46(10):1099&#x2013;107. doi: 10.1097/MLR.0b013e318185c92d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318185c92d</ArticleId><ArticleId IdType="pubmed">18815532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36 Suppl 1:S33&#x2013;47. doi: 10.1007/s40264-013-0097-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0097-8</ArticleId><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC, Greenland S. Good practices for quantitative bias analysis. Int J Epidemiol. 2014;43(6):1969&#x2013;85. doi: 10.1093/ije/dyu149</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu149</ArticleId><ArticleId IdType="pubmed">25080530</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner CA, Jacobs AD, Marques CK, Oates JC, Kamen DL, Anderson PE, et al.. Word2Vec inversion and traditional text classifiers for phenotyping lupus. BMC Med Inform Decis Mak. 2017;17(1):126. doi: 10.1186/s12911-017-0518-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-017-0518-1</ArticleId><ArticleId IdType="pmc">PMC5568290</ArticleId><ArticleId IdType="pubmed">28830409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, Thompson K, Skedgel C. Identification of patients with systemic lupus erythematosus in administrative healthcare databases. Lupus. 2014;23(13):1377&#x2013;82. doi: 10.1177/0961203314543917</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314543917</ArticleId><ArticleId IdType="pubmed">25057038</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkema EV, J&#xf6;nsen A, R&#xf6;nnblom L, Svenungsson E, Sj&#xf6;wall C, Simard JF. Case definitions in Swedish register data to identify systemic lupus erythematosus. BMJ open. 2016;6(1):e007769&#x2013;e. doi: 10.1136/bmjopen-2015-007769</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-007769</ArticleId><ArticleId IdType="pmc">PMC4716148</ArticleId><ArticleId IdType="pubmed">26729375</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, et al.. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine. 2010;28(4):1062&#x2013;8. doi: 10.1016/j.vaccine.2009.10.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.10.115</ArticleId><ArticleId IdType="pubmed">19896453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyree PT, Lind BK, Lafferty WE. Challenges of using medical insurance claims data for utilization analysis. American journal of medical quality: the official journal of the American College of Medical Quality. 2006;21(4):269&#x2013;75. doi: 10.1177/1062860606288774</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1062860606288774</ArticleId><ArticleId IdType="pmc">PMC1533763</ArticleId><ArticleId IdType="pubmed">16849784</ArticleId></ArticleIdList></Reference><Reference><Citation>Peabody JW, Luck J, Jain S, Bertenthal D, Glassman P. Assessing the accuracy of administrative data in health information systems. Med Care. 2004;42(11):1066&#x2013;72. doi: 10.1097/00005650-200411000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200411000-00005</ArticleId><ArticleId IdType="pubmed">15586833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>